Current market catalysts

HealthEquity (HQY) Q2 Earnings and Revenues Top Estimates

HealthEquity reported Q3 2026 earnings of $1.24 per share, beating consensus estimates of $1.19, with revenues of $350.73 million slightly exceeding expectations. The company has outperformed the S&P 500 by 2% year-to-date. However, the stock received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, suggesting near-term performance in line with the market.

Lowey Dannenberg, P.C. is Investigating Flotek Industries, Inc. (NYSE: FTK) for Potential Violations of the Federal Securities Laws

Law firm Lowey Dannenberg is investigating Flotek Industries (NYSE: FTK) for potential federal securities violations following the cancellation of a major $400 million PREPA power generation agreement. The contract represented 57% of Flotek's revenue backlog. After Wolfpack Research published a critical report on August 17, 2026, PREPA terminated the agreement, causing Flotek's stock to plunge $7.17 per share (20%) to $28.66. The investigation focuses on whether Flotek concealed risks and provided accurate information to investors.

3 Artificial Intelligence (AI) Stocks Hedge Funds Are Buying Hand Over Fist

Major hedge funds including Peter Thiel's fund, David Tepper's Appaloosa Management, and others loaded up on Amazon, Alphabet, and Taiwan Semiconductor during Q2. Amazon's AWS grew 37% YoY, Alphabet's Google Cloud surged 82%, and TSMC benefits as the world's largest chip supplier for AI computing. All three stocks are positioned as strong AI investment opportunities.

NetApp (NTAP) Just Overtook the 20-Day Moving Average

NetApp (NTAP) has broken through its 20-day moving average, suggesting a short-term bullish trend. The stock has risen 11.9% over the last four weeks and received 3 upward earnings estimate revisions with no downward revisions, indicating positive momentum. NTAP is currently rated as a Zacks Rank #3 (Hold) stock.

Parker-Hannifin (PH) Just Overtook the 20-Day Moving Average

Parker-Hannifin (PH) is showing bullish technical indicators after crossing above its 20-day moving average and reaching a key support level. The stock has gained 9.3% over the past four weeks and has received 9 positive earnings estimate revisions with no downward revisions, suggesting potential for further gains.

Royal Bank of Canada Q3 2026 Earnings Call: Complete Transcript

Royal Bank of Canada (TSX:RY) released third-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial

Sk Hynix CEO Says To Begin Volume Production Of Next-generation Hbm4e Chips At Indiana Facility In H2 2029; Indiana Expected To Become Key U.S. HBM Production Base

- Reuters

Barclays Maintains Equal-Weight on Bath & Body Works, Lowers Price Target to $22

Barclays analyst Adrienne Yih maintains Bath & Body Works (NYSE:BBWI) with a Equal-Weight and lowers the price target from $23 to $22.

Bernstein Maintains Outperform on JM Smucker, Raises Price Target to $157

Bernstein analyst Alexia Howard maintains JM Smucker (NYSE:SJM) with a Outperform and raises the price target from $137 to $157.

Barclays Maintains Equal-Weight on Abercrombie & Fitch, Raises Price Target to $155

Barclays analyst Adrienne Yih maintains Abercrombie & Fitch (NYSE:ANF) with a Equal-Weight and raises the price target from $114 to $155.

Urban Outfitters Analysts Boost Their Forecasts After Q2 Results

Urban Outfitters (URBN) reported mixed Q2 results, with adjusted earnings missing estimates and sales exceeding expectations. Stock decreased by 4.6%.

Full Transcript: Corby Spirit and Wine Q4 2026 Earnings Call

Corby Spirit and Wine (TSX:CSW) released fourth-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive

SPAM Maker Hormel Says Consumers Remain Strained As Inflation and Fuel Costs Pile Up

Hormel (HRL) stock dips 8.7% on Q3 results. Adjusted EPS beats at $0.37, but sales miss at $2.96B. Get full Q3 data & 2026 outlook updates.

NMTC stock has given up its prior gain. NeuroOne Medical Technologies shares were trading higher after the company announced it has completed three separate large-animal procedures using its next-generation StereoCED platform.

8-K filing — Federal Home Loan Bank of Topeka

Filed: 2026-08-27 AccNo: 0001325878-26-000172 Size: 162 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Bernstein Maintains Market Perform on CrowdStrike Holdings, Raises Price Target to $119

Bernstein analyst Peter Weed maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Market Perform and raises the price target from $103 to $119.

Revolution Medicines’ Pancreatic Cancer Drug Approval Validates Microcap Propanc Biopharma’s Breakthrough Survival Results

Propanc Biopharma reports strong preclinical data from pancreatic cancer drug, PRP, showing over 90% tumor inhibition and extended survival.

UBS Maintains Neutral on Ollie's Bargain Outlet, Lowers Price Target to $85

UBS analyst Mark Carden maintains Ollie's Bargain Outlet (NASDAQ:OLLI) with a Neutral and lowers the price target from $87 to $85.

QUICK SPARK: New Defiance ETF Targets the ‘Hidden’ Hardware Powering AI

Defiance’s new CAPA ETF targets capacitor makers powering AI servers, data centers and next-generation high-power infrastructure.

QUICK SPARK: Nvidia Stock Adds $370 Billion Market Value, A Whole Coca-Cola

Nvidia stock jumps 7.32%, adding $371.7 billion in market value after earnings. The AI giant now has a $5.4 trillion market cap.

Bernstein Maintains Outperform on Okta, Raises Price Target to $143

Bernstein analyst Peter Weed maintains Okta (NASDAQ:OKTA) with a Outperform and raises the price target from $141 to $143.

Bernstein Maintains Underperform on Salesforce, Raises Price Target to $195

Bernstein analyst Mark Moerdler maintains Salesforce (NYSE:CRM) with a Underperform and raises the price target from $173 to $195.

UBS Maintains Buy on Dycom Industries, Lowers Price Target to $525

UBS analyst Steven Fisher maintains Dycom Industries (NYSE:DY) with a Buy and lowers the price target from $611 to $525.

'JPMorgan Leads $5 Billion Debt Package for Volta AI Buildout' - Bloomberg

https://www.bloomberg.com/news/articles/2026-08-27/jpmorgan-leads-5-billion-debt-package-for-volta-ai-buildout

Bernstein Maintains Outperform on Agilent Technologies, Raises Price Target to $180

Bernstein analyst Eve Burstein maintains Agilent Technologies (NYSE:A) with a Outperform and raises the price target from $155 to $180.

UBS Maintains Buy on Dick's Sporting Goods, Lowers Price Target to $178

UBS analyst Michael Lasser maintains Dick's Sporting Goods (NYSE:DKS) with a Buy and lowers the price target from $275 to $178.

These Analysts Slash Their Forecasts On Bath & Body Works Following Q2 Results

Bath & Body Works (BBWI) reported strong Q2 results and raised its FY26 EPS guidance. Analysts have mixed opinions on the stock. BBWI shares fell 2.9%.

Hark Announces Multi-Year Partnership With NVIDIA To Advance Personalized Agentic AI Supported By Gigawatt-Scale Compute

Hark today announced a multi-year strategic partnership with NVIDIA to advance personalized agentic AI, including a deep technical collaboration and gigawatt-scale compute capacity on the next-generation NVIDIA Vera

Bernstein Maintains Outperform on NVIDIA, Raises Price Target to $400

Bernstein analyst Stacy Rasgon maintains NVIDIA (NASDAQ:NVDA) with a Outperform and raises the price target from $315 to $400.

QUICK SPARK: $3.8B SPY Exodus Meets $3.7B QQQ Inflow in One Day

QQQ attracted $3.67 billion in ETF inflows while SPY saw $3.82 billion in outflows, as semiconductor ETFs also drew strong investor demand.